| Page 1264 | Kisaco Research
 

Rachel Bartholomew

CEO & Founder
HyIvy

Rachel Bartholomew is a 2 time entrepreneur who is now working on her second company, Hyivy Health, created after her recent fight with cervical cancer. Hyivy Health is creating a pelvic rehabilitation device for the 1 in 3 women worldwide who will experience a pelvic health complication in their lifetime. Rachel is a graduate of the University of Waterloo and has been working in various roles in the entrepreneurship ecosystem for over 10 years.

Rachel Bartholomew

CEO & Founder
HyIvy

Rachel Bartholomew

CEO & Founder
HyIvy

Rachel Bartholomew is a 2 time entrepreneur who is now working on her second company, Hyivy Health, created after her recent fight with cervical cancer. Hyivy Health is creating a pelvic rehabilitation device for the 1 in 3 women worldwide who will experience a pelvic health complication in their lifetime. Rachel is a graduate of the University of Waterloo and has been working in various roles in the entrepreneurship ecosystem for over 10 years.

 

Peony Li

CEO & Founder
Jude

Peony Li

CEO & Founder
Jude

Peony Li

CEO & Founder
Jude
 

Natalie Waltz Fretwell

Founder
Tabu

Natalie Waltz is the founder of Tabu - a new kind of sexual wellness brand for bodies that change. Previously, Natalie was the VP of Marketing and Communications at The Chernin Group (TCG). Prior to that, she was an early employee at Collective Health, and recently served as a product advisor to Dadi. She started her career in the crisis communications practice group at Hill & Knowlton Strategies.

Natalie Waltz Fretwell

Founder
Tabu

Natalie Waltz Fretwell

Founder
Tabu

Natalie Waltz is the founder of Tabu - a new kind of sexual wellness brand for bodies that change. Previously, Natalie was the VP of Marketing and Communications at The Chernin Group (TCG). Prior to that, she was an early employee at Collective Health, and recently served as a product advisor to Dadi. She started her career in the crisis communications practice group at Hill & Knowlton Strategies.

 

Missy Lavendar

CEO & Founder
Renalis Health

Missy Lavendar

CEO & Founder
Renalis Health

Missy Lavendar

CEO & Founder
Renalis Health
 

Michelle Mielke

Professor of Epidemiology; Professor of Gerontology & Geriatric Medicine
Wake Forest School of Medicine

Michelle M. Mielke, Ph.D. is Chair of the Department of Epidemiology and Prevention and Professor of Epidemiology and of Gerontology and Geriatric Medicine at Wake Forest University School of Medicine. Dr. Mielke works as a translational epidemiologist to further understanding of the etiology and epidemiology of neurodegenerative and other aging-related diseases.  One focus of her research is understanding the utility of blood-based biomarkers at the population for screening and diagnosing Alzheimer’s disease and related dementias. Another focus of Dr.

Michelle Mielke

Professor of Epidemiology; Professor of Gerontology & Geriatric Medicine
Wake Forest School of Medicine

Michelle Mielke

Professor of Epidemiology; Professor of Gerontology & Geriatric Medicine
Wake Forest School of Medicine

Michelle M. Mielke, Ph.D. is Chair of the Department of Epidemiology and Prevention and Professor of Epidemiology and of Gerontology and Geriatric Medicine at Wake Forest University School of Medicine. Dr. Mielke works as a translational epidemiologist to further understanding of the etiology and epidemiology of neurodegenerative and other aging-related diseases.  One focus of her research is understanding the utility of blood-based biomarkers at the population for screening and diagnosing Alzheimer’s disease and related dementias. Another focus of Dr. Mielke’s research is on understanding sex and gender differences in the development and progression of Alzheimer’s disease and of other aging-related conditions. She directs the Mayo Clinic Specialized Center of Research Excellence (SCORE) on Sex Differences. Dr. Mielke is co-Chair of the Sex and Gender Diversity Group for the Alzheimer’s Association Professional Interest Area. She received the John R. Raymond Mentor Award from the Women Scholars Initiative. She is the PI of several NIH-funded clinical- and epidemiological-based grants and has published over 360 manuscripts.

 

Lucy Perez

PhD, Senior Principal
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

Lucy Perez

PhD, Senior Principal
McKinsey & Company

Lucy Perez

PhD, Senior Principal
McKinsey & Company

Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.

Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America.  She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.

 

Lina Borgo

CO- Founder
Mina Health

Lina Borgo

CO- Founder
Mina Health

Lina Borgo

CO- Founder
Mina Health
 

Kelle Moley

Global VP of Clinical and Translational R&D, Reproductive Medicine & Maternal Health
Ferring Pharmaceuticals

Kelle Moley

Global VP of Clinical and Translational R&D, Reproductive Medicine & Maternal Health
Ferring Pharmaceuticals

Kelle Moley

Global VP of Clinical and Translational R&D, Reproductive Medicine & Maternal Health
Ferring Pharmaceuticals
 

Kalahn Taylor-Clark

Faculty in Executive Education
The Johns Hopkins University

Kalahn Taylor-Clark

Faculty in Executive Education
The Johns Hopkins University

Kalahn Taylor-Clark

Faculty in Executive Education
The Johns Hopkins University
 

Jessica Karr

Founding General Partner
Coyote Ventures

Jessica Karr is a Founding General Partner of Coyote Ventures, an early stage venture capital fund investing in women’s health and wellness. Jessica worked for 6+ years designing and launching the Impossible burger as the 12th employee, has worked with international startups on product strategy and helped launched impact-focused funds. 

Jessica Karr

Founding General Partner
Coyote Ventures

Jessica Karr

Founding General Partner
Coyote Ventures

Jessica Karr is a Founding General Partner of Coyote Ventures, an early stage venture capital fund investing in women’s health and wellness. Jessica worked for 6+ years designing and launching the Impossible burger as the 12th employee, has worked with international startups on product strategy and helped launched impact-focused funds. 

Jessica Karr is a Founding General Partner of Coyote Ventures, an early stage venture capital fund investing in women’s health and wellness. Jessica worked for 6+ years designing and launching the Impossible burger as the 12th employee, has worked with international startups on product strategy and helped launched impact-focused funds.